Nykode Therapeutics ASA Logo

Nykode Therapeutics ASA

ISIN: NO0010714785 | Ticker: NYKD | LEI: 254900UKQHWYZJD22017
Sector: Health Care – Sub-Industry: Biotechnology
Country: Norway
Website Investor Relations

About Nykode Therapeutics ASA

Company Description

Nykode Therapeutics is a leading clinical-stage biopharmaceutical company. With our intelligent modular platform and tailored hyper-targeting, we’re unlocking unlimited possibilities for the future of medicine.

With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.

Year founded

2007

Served area

Worldwide

Headquarters

Gaustadalléen 21, 0349 Oslo – Norway

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

NO0010714785

LEI

254900UKQHWYZJD22017

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Oslo Børs

Main Stock Exchange

View Nykode Therapeutics ASA on stock exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.